Maria Eugenia Inzaugarat
Overview
Explore the profile of Maria Eugenia Inzaugarat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
734
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reissing J, Berres M, Strnad P, Wree A, Inzaugarat M, Trautwein C, et al.
Cell Mol Gastroenterol Hepatol
. 2023 Dec;
17(4):517-538.
PMID: 38158122
Background & Aims: Type 2 immune responses contribute to liver fibrosis in parasite infections, but their role in other liver diseases is less well understood. Here, we aimed at unravelling...
2.
Knorr J, Kaufmann B, Inzaugarat M, Holtmann T, Geisler L, Hundertmark J, et al.
Hepatology
. 2022 Sep;
77(6):1968-1982.
PMID: 36059147
Background And Aims: Nucleotide-binding oligomerization domain-like receptor-family pyrin domain-containing 3 (NLRP3) inflammasome activation has been shown to result in liver fibrosis. Mechanisms and downstream signaling remain incompletely understood. Here, we...
3.
Holtmann T, Inzaugarat M, Knorr J, Geisler L, Schulz M, Bieghs V, et al.
Cells
. 2021 Oct;
10(10).
PMID: 34685598
Bile acids (BA) as important signaling molecules are considered crucial in development of cholestatic liver injury, but there is limited understanding on the involved cell types and signaling pathways. The...
4.
Macias-Rodriguez R, Inzaugarat M, Ruiz-Margain A, Nelson L, Trautwein C, Cubero F
Int J Mol Sci
. 2020 Mar;
21(5).
PMID: 32121273
Ferroptosis has emerged as a new type of cell death in different pathological conditions, including neurological and kidney diseases and, especially, in different types of cancer. The hallmark of this...
5.
Wree A, Holtmann T, Inzaugarat M, Feldstein A
Semin Liver Dis
. 2019 May;
39(3):275-282.
PMID: 31100758
Hepatocyte demise as well as signals released by stressed hepatocytes have been now recognized as important triggers of liver inflammation. While traditional concepts classically viewed hepatocyte cell death to occur...
6.
Inzaugarat M, Johnson C, Holtmann T, McGeough M, Trautwein C, Papouchado B, et al.
Hepatology
. 2018 Sep;
69(2):845-859.
PMID: 30180270
The NLR family pyrin domain-containing 3 (NLRP3) inflammasome plays an important role in liver fibrosis (LF) development. However, the mechanisms involved in NLRP3-induced fibrosis are unclear. Our aim was to...
7.
Wree A, McGeough M, Inzaugarat M, Eguchi A, Schuster S, Johnson C, et al.
Hepatology
. 2017 Sep;
67(2):736-749.
PMID: 28902427
The NLRP3 inflammasome, a caspase-1 activation platform, plays a key role in the modulation of liver inflammation and fibrosis. Here, we tested the hypothesis that interleukin 17 (IL-17) and tumor...
8.
Wree A, Inzaugarat M, Feldstein A
Hepatology
. 2017 Sep;
67(1):438-441.
PMID: 28859227
No abstract available.
9.
Inzaugarat M, De Matteo E, Baz P, Lucero D, Garcia C, Gonzalez Ballerga E, et al.
PLoS One
. 2017 Mar;
12(3):e0172900.
PMID: 28257515
Introduction: The immune system acts on different metabolic tissues that are implicated in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Leptin and linoleic acid have the ability to potentially...
10.
Inzaugarat M, Wree A, Feldstein A
Hepatology
. 2016 May;
64(2):669-71.
PMID: 27239763
No abstract available.